Biotech News
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
Joint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-making WILMINGTON, Mass. --(BUSINESS WIRE)--Oct. 22, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a Research Collaboration Agreement
